Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,196 Cr
up ₹75.5 Cr vs Jun 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 70.5%
- of the portfolio in its ten largest
- Cash & debt
- −<0.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2022 it disclosed 24 stocks worth ₹1,196 Cr, up ₹75.5 Cr from Jun 2022. Its largest positions were Sun Pharmaceutical Industries Limited (15.7%), Cipla Limited (9.6%), Max Healthcare Institute Limited (7.5%); the ten largest together made up 70.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 57.0% of its equity. Cash and debt stood at −<0.1%. Compared with Jun 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
1%
Holds more cash than 1% of peers
What these mean: concentration · cash
Holdings in July 2022
Download CSVEvery line the fund disclosed, with the change against Jun 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 15.72% | up 0.84 pts | ₹188 Cr | up ₹21.3 Cr | Added |
| Cipla Limited | 9.59% | down 0.11 pts | ₹115 Cr | up ₹6 Cr | Added |
| Max Healthcare Institute Limited | 7.46% | down 0.44 pts | ₹89.2 Cr | up ₹65 L | Added |
| Apollo Hospitals Enterprise Limited | 6.75% | up 0.45 pts | ₹80.7 Cr | up ₹10.1 Cr | Added |
| IPCA Laboratories Limited | 6.61% | up 0.28 pts | ₹79 Cr | up ₹8.1 Cr | Added |
| Procter & Gamble Health Limited | 5.88% | down 0.05 pts | ₹70.4 Cr | up ₹3.8 Cr | Added |
| Dr. Reddy's Laboratories Limited | 5.73% | down 0.84 pts | ₹68.5 Cr | down ₹5.1 Cr | Trimmed |
| Lupin Limited | 4.63% | down 0.06 pts | ₹55.3 Cr | up ₹2.8 Cr | Added |
| Alkem Laboratories Limited | 4.53% | up 0.03 pts | ₹54.2 Cr | up ₹3.8 Cr | Added |
| Indoco Remedies Limited | 3.62% | down 0.06 pts | ₹43.3 Cr | up ₹2.1 Cr | Added |
| Vijaya Diagnostic Centre Limited | 2.91% | down 0.12 pts | ₹34.8 Cr | up ₹85 L | Added |
| Intuitive Surgical Inc | 2.87% | up 0.20 pts | ₹34.3 Cr | up ₹4.4 Cr | Added |
| Globus Medical Inc | 2.61% | down 0.06 pts | ₹31.2 Cr | up ₹1.3 Cr | Added |
| Abiomed Inc | 2.61% | up 0.24 pts | ₹31.2 Cr | up ₹4.7 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.46% | up 0.05 pts | ₹29.5 Cr | up ₹2.4 Cr | Added |
| Abbott Laboratories | 2.28% | down 0.11 pts | ₹27.3 Cr | up ₹46 L | Added |
| Syngene International Limited | 2.21% | down 0.09 pts | ₹26.4 Cr | up ₹61 L | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.88% | up 0.17 pts | ₹22.5 Cr | up ₹3.3 Cr | Added |
| Aarti Drugs Limited | 1.64% | down 0.05 pts | ₹19.6 Cr | up ₹70 L | Added |
| Unichem Laboratories Limited | 1.63% | up 0.22 pts | ₹19.5 Cr | up ₹3.7 Cr | Added |
| Alembic Pharmaceuticals Limited | 1.59% | down 0.17 pts | ₹19.1 Cr | down ₹71 L | Trimmed |
| Kovai Medical Center and Hospital Limited | 1.25% | down 0.04 pts | ₹14.9 Cr | up ₹47 L | Added |
| Illumina Inc | 1.21% | up 0.12 pts | ₹14.5 Cr | up ₹2.2 Cr | Added |
| MedPlus Health Services Limited | 1.19% | down 0.12 pts | ₹14.3 Cr | down ₹49 L | Trimmed |
| Narayana Hrudayalaya Limited | 1.13% | down 0.12 pts | ₹13.5 Cr | down ₹51 L | Trimmed |
| Cash, TREPS & receivables | −<0.01% | down 0.13 pts | −₹2 L | down ₹1.5 Cr | Trimmed |
What changed, Jun 2022 to Jul 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹21.3 Cr (+0.84% pts)
- Apollo Hospitals Enterprise Limitedup ₹10.1 Cr (+0.45% pts)
- IPCA Laboratories Limitedup ₹8.1 Cr (+0.28% pts)
- Cipla Limitedup ₹6 Cr (−0.11% pts)
- Abiomed Incup ₹4.7 Cr (+0.24% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2022, the weight rose most in Healthcare Equipment & Supplies (+0.1 pts), and fell most in Retailing (−0.1 pts) and Pharmaceuticals & Biotechnology (−0.1 pts).
- Healthcare Equipment & Supplies5.4% → 5.6%+0.1 pts
- Retailing1.3% → 1.2%−0.1 pts
- Pharmaceuticals & Biotechnology57.1% → 57.0%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2019 | Jul 2021 | Jan 2022 | Apr 2022 | Jun 2022 | Jul 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.4% | 60.8% | 54.0% | 55.4% | 57.1% | 57.0% |
| Healthcare Services | 16.7% | 23.3% | 29.3% | 28.0% | 26.0% | 26.0% |
| Pharmaceuticals | 11.7% | 7.2% | 7.0% | 7.1% | 7.6% | 7.7% |
| Healthcare Equipment & Supplies | — | 6.2% | 5.5% | 5.5% | 5.4% | 5.6% |
| Insurance | 2.2% | 2.5% | 2.6% | 2.5% | 2.5% | 2.5% |
| Retailing | — | — | 1.6% | 1.5% | 1.3% | 1.2% |
Allocation in Jul 2022change vs Jun 2022
- Pharmaceuticals & Biotechnology (9)57.0%▼ 0.1 pts
- Healthcare Services (8)26.0%
- Pharmaceuticals (3)7.7%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jul 2022
−<0.1%
▼ 0.1 pts vs Jun 2022
- Cash alone
- <0.1%
- cash and net receivables
- A year earlier
- 3.3%
- Jul 2021 · now ▼ 3.3 pts
- Last 12 months
- −0.3% – 3.7%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.